Oppenheimer Asset Management Inc. lowered its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 3.1% during the fourth quarter, Holdings Channel reports. The fund owned 158,088 shares of the conglomerate’s stock after selling 5,046 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Danaher were worth $36,190,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. JPL Wealth Management LLC acquired a new stake in Danaher during the third quarter valued at $25,000. Elevated Capital Advisors LLC acquired a new stake in Danaher during the fourth quarter valued at $26,000. WFA of San Diego LLC acquired a new stake in Danaher during the second quarter valued at $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher during the third quarter valued at $27,000. Finally, TruNorth Capital Management LLC acquired a new stake in shares of Danaher in the third quarter valued at about $28,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Price Performance
Danaher stock opened at $179.19 on Friday. The company’s 50 day simple moving average is $193.34 and its 200-day simple moving average is $213.15. The company has a market capitalization of $126.83 billion, a price-to-earnings ratio of 34.66, a price-to-earnings-growth ratio of 2.39 and a beta of 0.95. Danaher Corporation has a 1 year low of $175.00 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87.
Danaher Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 24th. Investors of record on Friday, March 27th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. This is an increase from Danaher’s previous quarterly dividend of $0.32. The ex-dividend date was Friday, March 27th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.
Wall Street Analyst Weigh In
DHR has been the topic of several research analyst reports. Guggenheim dropped their target price on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Morgan Stanley decreased their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 price target on shares of Danaher in a research note on Tuesday, April 21st. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Finally, Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Eighteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $240.70.
Insider Buying and Selling at Danaher
In related news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 10.80% of the company’s stock.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
